NDC 0009-3375-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0009-3375
- Requested NDC
- 0009-3375-01
- Package NDCs from labels
- 0009-3375-01, 0009-3375-02
- Manufacturer
- Pharmacia & Upjohn Company LLC
- Effective date
- 2026-07-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Pharmacia & Upjohn Company LLC | Pharmacia & Upjohn Company LLC | 2026-07-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0009-3375-01 | Cleocin Phosphate | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 59 | |
| 0009-3375-02 | Cleocin Phosphate | 2 in 1 PACKAGE | INJECTION, SOLUTION | 2 | 59 | |
| 0009-3375-02 | Cleocin Phosphate | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | 59 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0009-3375 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION CLEOCIN PHOSPHATE (0009-6582) (STANDALONE) (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [PHARMACIA & UPJOHN COMPANY LLC] | 55 | Legacy NDC, 3 package rows | 20250406_05a75685-0af5-407c-ac57-e380c882b49d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0009-3375-02 | ML - Milliliter | 0009-3375 | 099fea4b-feb8-48fb-8afd-627791b1ca6c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | c22fb382-afbc-4b2d-bdce-e97e21bddb23 | 2026-04-14 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindacin ETZ | CLINDAMYCIN PHOSPHATE | Eurofarma, Inc. | 89fed26e-1cad-4c0b-8695-d6f3562ba8d5 | 2026-04-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 34f7a271-c012-6463-e063-6394a90ad1ea | 2026-03-31 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE 1% | Preferred Pharmaceuticals Inc. | ea8d75ef-0e9b-4177-99f7-c901eb44f888 | 2026-03-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Preferred Pharmaceuticals Inc | e06d419f-4b60-405b-9459-e01bbb8d151d | 2026-03-30 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 311c05c2-a2b2-4051-b0b9-0427015aa980 | 2026-03-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Rising Pharma Holdings, Inc. | cc8262fe-8e41-49b2-97ae-7985e9a894e9 | 2026-03-24 | Warnings, Adverse reactions | EH6D7113I8 |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Cleocin | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 3db26227-208d-4fdd-8426-1d9be5cda9b4 | 2026-03-09 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 5c08f86e-abd7-4717-b902-74ea336ce28a | 2026-03-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin in 5 Percent Dextrose | CLINDAMYCIN IN 5 PERCENT DEXTROSE | Sandoz Inc | 231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 309336 309339 309335 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE GEL USP, 1% | Encube Ethicals, Inc. | ac21d7ad-f94e-4d57-95e3-1648add7ad0b | 2026-02-25 | Warnings, Adverse reactions | EH6D7113I8 |
| XACIATO | CLINDAMYCIN PHOSPHATE | Organon LLC | 0423007f-28fa-4159-bf58-9174626d2347 | 2026-02-19 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Henry Schein, Inc. | 8a4e2ba4-90e6-48e8-a943-0c5d3f169780 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 1737581 1737578 1737244 EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE USP, 1% | A-S Medication Solutions | 193a4b02-910f-46b2-8b61-25efea694720 | 2026-02-02 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin and benzoyl peroxide | CLINDAMYCIN AND BENZOYL PEROXIDE | Glenmark Pharmaceuticals Inc., USA | 76795d1b-e1f2-4d1d-b42a-f1d4448c63c0 | 2026-01-31 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d0ec3e88-40d9-4919-afc3-cf2e7e863376 | 2026-01-29 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 997a23c8-f0d7-49d5-af33-e11f2ddab3c7 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d36bad26-f337-4a71-a6e5-d97b60f4e385 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 62a2019f-7410-4251-95ed-181925ade6e4 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.